세이프티 니들 시장 보고서 : 제품별, 용도별, 최종사용자별, 지역별(2025-2033년)

The global safety needles market size reached USD 3.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.4 Billion by 2033, exhibiting a growth rate (CAGR) of 8.6% during 2025-2033.

Safety needles are used to deliver drugs, collect fluids from the body, and prevent the spread of needlestick injuries or infections associated with healthcare provision. They protect healthcare workers and patients from bloodborne pathogens and hazardous drug exposure. Some of the widely available safety needles are biopsy, Huber, cannula, pen, suture, prefilled, hypodermic, fine aspirating, intravenous (IV) catheter, blood collection, arteriovenous (AV) fistula, and spinal anesthesia and epidural. Nowadays, automated pen needles with built-in safety features are being introduced to provide various benefits in insulin injection.

Safety Needles Market Trends:

Injections are considered a main source of infection in transmitting bloodborne diseases, such as Hepatitis B, D, and C and Human Immunodeficiency Virus (HIV). As a result, health agencies of several countries are implementing laws for safe injection practices, which represents one of the major factors impelling the growth of the market. Safety needles help reduce the incidences of iatrogenic infection and save costs. In addition, they are used to prevent the transmission risk of bloodborne viruses and protect patients from needlestick injuries while administering coronavirus disease (COVID-19) vaccines. Apart from this, due to the growing prevalence of chronic diseases and awareness about the risk associated with filled syringes, there is a rise in the adoption of prefilled syringes across the globe, which, in turn, is driving the market. Moreover, several health firms are introducing needle-based safety devices that can be attached to a conventional or prefilled syringe. Furthermore, initiatives undertaken by governing agencies of numerous countries for needle disposal are projected to aid the market growth. For instance, a program was launched in the City of Bloomington (United States) to install sharps containers in public parks and address the increasing number of used syringes.

Key Market Segmentation:

Breakup by Product:

• Active Safety Needles
• Passive Safety Needles
• Others

Breakup by Application:

• Drug Delivery
• Sample Collection
• Injection

Breakup by End User:

• Hospitals and Ambulatory Surgery Centers
• Diabetic Patients
• Family Practice
• Psychiatry
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Becton Dickinson and Company, Boston Scientific Corporation, Cardinal Health Inc., Johnson & Johnson, Nipro Corporation, Novo Nordisk A/S, Retractable Technologies Inc., Smiths Group plc, Terumo Corporation and Vygon.

Key Questions Answered in This Report:

• How has the global safety needles market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global safety needles market?
• What are the key regional markets?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the application?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global safety needles market and who are the key players?
• What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Safety Needles Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Active Safety Needles
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Passive Safety Needles
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Others
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Application

• 7.1 Drug Delivery
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Sample Collection
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Injection
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals and Ambulatory Surgery Centers
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Diabetic Patients
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Family Practice
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Psychiatry
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 B. Braun Melsungen AG
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 SWOT Analysis
  • 14.3.2 Becton Dickinson and Company
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Boston Scientific Corporation
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Cardinal Health Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 Johnson & Johnson
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Nipro Corporation
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Novo Nordisk A/S
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Retractable Technologies Inc.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
  • 14.3.9 Smiths Group plc
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Terumo Corporation
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 Financials
    • 14.3.10.4 SWOT Analysis
  • 14.3.11 Vygon
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio